December 28, 2021 Updated 6:28 P.M. ET
TALLAHASSEE (FCV) – Tuesday, FCV was given access to a letter that Florida Surgeon General Joseph Ladapo sent to the Biden Administration, blasting its decision to limit COVID-19 therapeutics to the state.
“The federal government is actively preventing the effective distribution of monoclonal antibody treatments in the U.S.,” he said.
“The sudden suspension of multiple monoclonal antibody therapy treatments from distribution to Florida removes a health care provider’s ability to decide the best treatment options for their patients in this state.”
Florida has faced shortages of monoclonal antibody treatment due to the U.S. Department of Health and Human Services (HHS) cutting allocations. Florida Governor Ron DeSantis (R) promptly sought a different brand due to this shortage, but the HHS is still causing shortages.
Florida is facing both Delta and Omicron COVID-19 cases. Surgeon General Ladapo is requesting that the federal government not artificially determine Florida’s therapeutic needs.
“I respectfully request that you allow states and healthcare practitioners to provide treatment options that best benefit the communities they know and serve,” he wrote.
Share This Post
Florida’s Voice is a patriotic news network that you can trust to deliver the truth with no hidden agenda. Founder and Editor in Chief Brendon Leslie left his job in mainstream news to practice journalism as it should be, unbiased and unbossed.